We are live on ! Find out more
SURF

Surface Oncology, Inc. Common Stock
SURF

Delisted

SURF was delisted on the 7th of September, 2023.

Back to rankings

50 hedge funds and large institutions have $70.5M invested in Surface Oncology, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 23 increasing their positions, 9 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 4

156% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 9

16% more funds holding

Funds holding: 43 → 50 (+7)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

63% less capital invested

Capital invested by funds: $191M → $70.5M (-$121M)

Holders
50
Holders Change
+7
Holders Change %
+16.28%
% of All Funds
1.11%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
23
Reduced
9
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
+$6.93M
2
BlackRock
BlackRock
New York
+$3.83M
3
BCM
Bridgeway Capital Management
Texas
+$766K
4
BI
BVF Inc
California
+$708K
5
Fidelity International
Fidelity International
Bermuda
+$644K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$12.9M
2
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$5.25M
3
Citadel Advisors
Citadel Advisors
Florida
-$2.81M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$1.93M
5
Millennium Management
Millennium Management
New York
-$1.56M
Name Holding Trade Value Shares
Change 		Change in
Stake
Jacobs Levy Equity Management
26
Jacobs Levy Equity Management
New Jersey
$149K +$177K +22,900 +187%
TCIM
27
TIAA CREF Investment Management
New York
$143K +$179K +23,240 +221%
SO
28
STRS Ohio
Ohio
$137K +$137K +17,800 +122%
AIM
29
Alambic Investment Management
California
$127K +$232K +30,066 New
JP Morgan Chase
30
JP Morgan Chase
New York
$110K +$187K +24,239 +1,440%
SIM
31
Spark Investment Management
New York
$109K +$200K +25,900 New
Wells Fargo
32
Wells Fargo
California
$89K +$153K +19,772 +1,781%
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$63K +$28.8K +3,725 +33%
Acadian Asset Management
34
Acadian Asset Management
Massachusetts
$56K +$103K +13,329 New
Deutsche Bank
35
Deutsche Bank
Germany
$50K -$830K -107,519 -90%
ProShare Advisors
36
ProShare Advisors
Maryland
$45K +$81.7K +10,574 New
New York State Common Retirement Fund
37
New York State Common Retirement Fund
New York
$34K – – –
AIG
38
American International Group
New York
$32K +$20.2K +2,620 +54%
MAM
39
Meeder Asset Management
Ohio
$30K +$52.9K +6,856 New
Russell Investments Group
40
Russell Investments Group
United Kingdom
$15K +$27K +3,500 New
TRCT
41
Tower Research Capital (TRC)
New York
$11K +$6.53K +845 +47%
Citigroup
42
Citigroup
New York
$10K +$2.98K +386 +19%
UBS Group
43
UBS Group
Switzerland
$9K -$49.1K -6,352 -76%
BBHC
44
Brown Brothers Harriman & Co
New York
$8K +$14.2K +1,838 New
Legal & General Group
45
Legal & General Group
United Kingdom
$5K – – –
AIP
46
Ameritas Investment Partners
Nebraska
$2K – – –
AG
47
Advisor Group
Arizona
$1K – – –
Bank of Montreal
48
Bank of Montreal
Ontario, Canada
$1K +$842 +109 +218%
BNP Paribas Financial Markets
49
BNP Paribas Financial Markets
France
$547 -$842 -109 -46%
Lord, Abbett & Co
50
Lord, Abbett & Co
New Jersey
– -$5.25M -479,905 Closed
1
2
3

SURF Hedge Fund Activity: Q4 2018 in Review

50 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Surface Oncology, Inc. Common Stock (SURF) for Q4 2018, worth a combined $70.5M — down 63% from $191M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new SURF positions and 4 closed out — a net gain of 7 holders — while 23 added to existing stakes and 9 trimmed.

The largest buyer was EcoR1 Capital, adding an estimated $6.93M. The largest seller was Fidelity Investments, cutting an estimated $12.9M.

  • 50 institutional investors held Surface Oncology, Inc. Common Stock (SURF) as of Q4 2018, up from 43 in Q3 2018.
  • Funds reported $70.5M of Surface Oncology, Inc. Common Stock stock for Q4 2018, down 63% quarter-over-quarter.
  • 11 funds opened new Surface Oncology, Inc. Common Stock positions in Q4 2018 and 4 closed out, a net change of +7 holders.
  • The largest Surface Oncology, Inc. Common Stock buyer in Q4 2018 was EcoR1 Capital, an estimated $6.93M added.
  • The largest Surface Oncology, Inc. Common Stock seller in Q4 2018 was Fidelity Investments, an estimated $12.9M sold.

Based on aggregated 13F filings for Q4 2018.